Analystreport

CytomX Therapeutics Inc (NASDAQ: CTMX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com